Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing.
Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing.
复制标题
DOI:
10.1084/jem.192.8.1197
复制
发表时间:
2000-10-16
期刊:
影响因子:
--
通讯作者:
Gronert K
中科院分区:
文献类型:
--
作者:
Serhan CN;Clish CB;Brannon J;Colgan SP;Chiang N;Gronert K
Aspirin therapy inhibits prostaglandin biosynthesis without directly acting on lipoxygenases, yet via acetylation of cyclooxygenase 2 (COX-2) it leads to bioactive lipoxins (LXs) epimeric at carbon 15 (15-epi-LX, also termed aspirin-triggered LX [ATL]). Here, we report that inflammatory exudates from mice treated with ω-3 polyunsaturated fatty acid and aspirin (ASA) generate a novel array of bioactive lipid signals. Human endothelial cells with upregulated COX-2 treated with ASA converted C20:5 ω-3 to 18R-hydroxyeicosapentaenoic acid (HEPE) and 15R-HEPE. Each was used by polymorphonuclear leukocytes to generate separate classes of novel trihydroxy-containing mediators, including 5-series 15R-LX5 and 5,12,18R-triHEPE. These new compounds proved to be potent inhibitors of human polymorphonuclear leukocyte transendothelial migration and infiltration in vivo (ATL analogue > 5,12,18R-triHEPE > 18R-HEPE). Acetaminophen and indomethacin also permitted 18R-HEPE and 15R-HEPE generation with recombinant COX-2 as well as ω-5 and ω-9 oxygenations of other fatty acids that act on hematologic cells. These findings establish new transcellular routes for producing arrays of bioactive lipid mediators via COX-2–nonsteroidal antiinflammatory drug–dependent oxygenations and cell–cell interactions that impact microinflammation. The generation of these and related compounds provides a novel mechanism(s) for the therapeutic benefits of ω-3 dietary supplementation, which may be important in inflammation, neoplasia, and vascular diseases.
登录
查看更多内容
影响因子:
2.9
作者:
SERHAN, CN;MADDOX, JF;MADARA, JL
通讯作者:
MADARA, JL
影响因子:
4.8
作者:
Capdevila, JH;Wei, SZ;Peterson, JA
通讯作者:
Peterson, JA
影响因子:
9.3
作者:
Herschman, HR
通讯作者:
Herschman, HR
影响因子:
2.9
作者:
SERHAN, CN;WONG, PYK;SAMUELSSON, B
通讯作者:
SAMUELSSON, B
影响因子:
2.9
作者:
Xiao, GS;Tsai, AL;Kulmacz, RJ
通讯作者:
Kulmacz, RJ